After applying for MDACS registration of Class III in vitro diagnostic medical devices in Hong Kong, manufacturers must adhere to various regulations and requirements to ensure compliance and maintain the registration status of their devices. Here are the key regulations and requirements to follow:
1. Regulatory Compliance
- Adhere to MDCO Guidelines: Continuously comply with the guidelines and requirements set forth by the Medical Device Control Office (MDCO). This includes any updates or changes in regulations that may affect your device.
2. Quality Management System (QMS) Maintenance
- Implement ISO 13485: Ensure ongoing compliance with ISO 13485 or an equivalent standard for the Quality Management System. This involves:
- Regular internal audits.
- Management reviews to assess the effectiveness of the QMS.
- Continuous improvement based on audit findings and user feedback.
3. Post-Market Surveillance (PMS)
- Monitor Device Performance: Implement a post-market surveillance plan to monitor the safety and effectiveness of the device once it is on the market. This includes:
- Collecting and analyzing data on device performance.
- Tracking adverse events and user complaints.
4. Adverse Event Reporting
- Report Serious Incidents: Establish a clear procedure for reporting serious incidents or adverse events related to the device to the MDCO. This involves:
- Promptly notifying the MDCO of any adverse events that could impact patient safety.
- Documenting all incidents and responses in a traceable manner.
5. Device Modifications and Changes
- Assess Impact of Changes: If there are any changes to the device, such as design modifications, new indications for use, or alterations in manufacturing processes, evaluate whether these changes necessitate re-evaluation or re-registration with the MDCO.
- Conduct Additional Studies if Needed: Depending on the nature of the changes, you may need to conduct additional clinical evaluations or risk assessments.
6. Documentation and Record Keeping
- Maintain Comprehensive Records: Keep detailed records of all post-market activities, including:
- PMS data.
- Adverse event reports.
- Quality control records and audit findings.
- Ensure Traceability: Maintain traceability of all device-related documents and changes for regulatory inspections or audits.
7. User Training and Support
- Provide Training Resources: Offer adequate training and resources for users of the device to ensure proper usage and safety. This includes:
- Updating instructions for use (IFU) as necessary based on user feedback or regulatory updates.
8. Periodic Reviews and Updates
- Review Regulatory Requirements: Regularly review and update your knowledge of regulatory requirements and best practices to ensure ongoing compliance.
- Conduct Regular Risk Assessments: Continuously assess risks associated with the device, especially as new information or incidents arise.
9. Engage with Regulatory Authorities
- Communicate with MDCO: Maintain open communication with the MDCO for any guidance or clarification needed regarding compliance and reporting obligations.
10. International Market Compliance (if applicable)
- Adhere to International Regulations: If the device is marketed internationally, ensure compliance with regulatory requirements in other jurisdictions where the device is sold, such as the FDA in the USA or the European Medicines Agency (EMA) for the European Union.
Conclusion
Adhering to these regulations and requirements after applying for MDACS registration is crucial for ensuring the safety, quality, and efficacy of Class III in vitro diagnostic medical devices. By maintaining compliance and implementing robust post-market practices, manufacturers can support the long-term success and acceptance of their devices in the market.

Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn